報價延遲最少15分鐘:2026/03/12 02:26 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
59.97 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
4.89/2.18
|
|
企業價值
1.73B
|
| 資產負債 |
|
每股賬面淨值
27.32
|
| 現金流量 |
|
現金流量率
0.07
|
| 損益表 |
|
收益
911.98M
|
|
每股收益
19.94
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region. |
